[go: up one dir, main page]

NO961242D0 - Fremgangsmåte for fremstilling av faste dispersjoner og depoter såvel som faste medisinske former med dihydropyridin-type kalsium-antagonister - Google Patents

Fremgangsmåte for fremstilling av faste dispersjoner og depoter såvel som faste medisinske former med dihydropyridin-type kalsium-antagonister

Info

Publication number
NO961242D0
NO961242D0 NO961242A NO961242A NO961242D0 NO 961242 D0 NO961242 D0 NO 961242D0 NO 961242 A NO961242 A NO 961242A NO 961242 A NO961242 A NO 961242A NO 961242 D0 NO961242 D0 NO 961242D0
Authority
NO
Norway
Prior art keywords
solid
depots
dihydropyridine
preparation
well
Prior art date
Application number
NO961242A
Other languages
English (en)
Other versions
NO961242L (no
Inventor
Franc Vrecer
Marija Filipcic-Mocnik
Jozica Gustin
Original Assignee
Krka Tovarna Zdravil
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Krka Tovarna Zdravil filed Critical Krka Tovarna Zdravil
Publication of NO961242D0 publication Critical patent/NO961242D0/no
Publication of NO961242L publication Critical patent/NO961242L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO961242A 1993-09-28 1996-03-27 Fremgangsmåte for fremstilling av faste dispersjoner og depoter såvel som faste medisinske former med dihydropyridin-type kalsium-antagonister NO961242L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SI9300504A SI9300504A (en) 1993-09-28 1993-09-28 Process for preparation solid dispersions and deposits of calcium antagonist dihidropyrimidine derivates and pharmaceutical compositions comprising the same
PCT/SI1994/000017 WO1995008987A1 (en) 1993-09-28 1994-09-26 Process for preparation of solid disperions and deposits as well as of solid medicinal forms with dihydropyridine type calcium antagonists

Publications (2)

Publication Number Publication Date
NO961242D0 true NO961242D0 (no) 1996-03-27
NO961242L NO961242L (no) 1996-05-09

Family

ID=20431250

Family Applications (1)

Application Number Title Priority Date Filing Date
NO961242A NO961242L (no) 1993-09-28 1996-03-27 Fremgangsmåte for fremstilling av faste dispersjoner og depoter såvel som faste medisinske former med dihydropyridin-type kalsium-antagonister

Country Status (11)

Country Link
EP (1) EP0721329A1 (no)
CZ (1) CZ90096A3 (no)
FI (1) FI961394A7 (no)
HR (1) HRP940611A2 (no)
HU (1) HUT75643A (no)
NO (1) NO961242L (no)
PL (1) PL313712A1 (no)
SI (1) SI9300504A (no)
SK (1) SK37996A3 (no)
WO (1) WO1995008987A1 (no)
YU (1) YU56494A (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2133052B1 (es) * 1996-04-29 2000-05-01 Almirall Prodesfarma Sa Nuevas formulaciones farmaceuticas liquidas para la via oral.
US5985248A (en) * 1996-12-31 1999-11-16 Inhale Therapeutic Systems Processes for spray drying solutions of hydrophobic drugs and compositions thereof
ES2125198B1 (es) * 1997-05-13 1999-11-16 Vita Invest Sa Asociacion a dosis fija de un inhibidor de la enzima convertidora de angiotensina y de un antagonista de los canales de calcio, procedimiento para su preparacion y su utilizacion para el tratamiento de enfermees cardiovasculares.
DK1487416T3 (da) * 2002-03-26 2010-03-29 Teva Pharma Lægemiddelmikropartikler
KR20040011248A (ko) * 2002-07-30 2004-02-05 환인제약 주식회사 암로디핀의 고체분산체와 그 제조방법 및 그를 포함하는약학적 조성물
ITMI20131485A1 (it) 2012-09-10 2014-03-11 Rivopharm Sa Composizione farmaceutica comprendente lacipidina e processo di preparazione
CN104095811A (zh) * 2013-04-09 2014-10-15 上海信谊药厂有限公司 尼莫地平纳米混悬剂及其制备方法
CN109010288B (zh) * 2018-07-27 2020-12-08 洛阳瑞华动物保健品有限公司 一种提高二氢吡啶固体制剂稳定性工艺

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1579818A (en) * 1977-06-07 1980-11-26 Yamanouchi Pharma Co Ltd Nifedipine-containing solid preparation composition
EP0001247A1 (en) * 1977-09-14 1979-04-04 Kanebo, Ltd. Pharmaceutical preparation containing nifedipine and a method for producing the same.
DE3433239A1 (de) * 1984-09-11 1986-03-20 Bayer Ag, 5090 Leverkusen Feste arzneizubereitung enthaltend nitrendipin und verfahren zu ihrer herstellung
FR2613619B1 (fr) * 1987-04-07 1993-10-15 Recherche Informatique Pharmacie Medicaments, produits dietetiques ou produits d'hygiene sous forme de compositions pulverulentes obtenues par adsorption de principes actifs sur un sucre a dissolution rapide
US5316772A (en) * 1990-12-19 1994-05-31 Solvay & Cie, S.A. (Societe Anonyme) Bilayered oral pharmaceutical composition with pH dependent release
JP3110794B2 (ja) * 1991-06-05 2000-11-20 ユーシービージャパン株式会社 １，４−ジヒドロピリジン誘導体を含有する製剤

Also Published As

Publication number Publication date
HUT75643A (en) 1997-05-28
WO1995008987A1 (en) 1995-04-06
FI961394A0 (fi) 1996-03-27
CZ90096A3 (en) 1996-09-11
FI961394A7 (fi) 1996-03-27
PL313712A1 (en) 1996-07-22
NO961242L (no) 1996-05-09
SK37996A3 (en) 1997-02-05
HU9600741D0 (en) 1996-05-28
HRP940611A2 (en) 1996-10-31
SI9300504A (en) 1995-04-30
EP0721329A1 (en) 1996-07-17
YU56494A (sh) 1997-03-07

Similar Documents

Publication Publication Date Title
NZ241211A (en) 16alpha,17alpha-alkylidenedioxy-11b,21-dihydroxypregan -4-ene-3,20-dione derivatives substituted by halogen in either or both of the 6alpha- or the 9alpha- position; pharmaceutical compositions, methods of preparation and treatment
NO944164D0 (no) Fremgangsmåte for fremstilling og anvendelse av en HCl-adsorbent
NO900439D0 (no) Fremgangsmaate for behandling av uorganisk pulver.
WO2002074337A8 (en) Hmgb1 protein inhibitors and/or antagonists for the treatment of vascular diseases
NO964966L (no) Lactobacillusstammer av human opprinnelse, blandinger samt anvendelse derav
NO961006L (no) Fosfonomononukleinsyrer, fremgangsmåter for fremstilling derav og anvendelse av forbindelsene
IS3703A7 (is) Aðferð til framleiðslu á efnasamsetningu til lækninga, sem er samverkandi og starfsmagnandi og aðferðir við notkun hennar
NZ241210A (en) 16alpha,17alpha-butylidenedioxy-11b, 21-dihydroxypregn-4-ene-3,20-dione derivatives substituted in either or both the 6alpha- and 9alpha- positions by fluorine; pharmaceutical compositions, methods of preparation and treatment
NO913621D0 (no) Sementblanding og fremgangsmaate for fremstilling av blandingen.
FI940874A0 (fi) Menetelmä maitohapon ja maitohappoestereiden valmistamiseksi
NO932791L (no) Fremgangsmaate for fremstilling av titandioksyd
UA41355C2 (uk) Засіб для лікування нейро-сніду
NO922426L (no) Forbindelser med reninhemmende egenskaper, fremgangsmaate for fremstilling av disse og deres anvendelse
IE882628L (en) Substituted 2-phenyl-4-quinoline carboxylic acids
NO961242D0 (no) Fremgangsmåte for fremstilling av faste dispersjoner og depoter såvel som faste medisinske former med dihydropyridin-type kalsium-antagonister
NO306347B1 (no) Eleutherobin og analoger av denne, anvendelse av forbindelsen samt farmasöytisk preparat inneholdende denne
HUP9902415A3 (en) Solid instant-release forms of administration and process for producing the same
IS4158A (is) Aðferð til framleiðslu á azamacrocyclic eða acyclic amínofosfónat esterum og afleiðum þeirra
FI961378A0 (fi) Menetelmä N-metyyli-3-(1-metyyli-4-piperidinyyli)-14-indoli-5-etaanisulfonamidin valmistamiseksi
NO870104D0 (no) Farmasoeytisk preparat med vedvarende frigivelse av den aktive komponenten og fremgangsmaate for fremstilling derav.
DE69209621D1 (de) Selektive Gasphasen-Chlorierung von polychlorierten Beta-Pikolinen zur Herstellung von 2,3,5,6-Tetrachlorpyridin sowie dessen Vorprodukte
WO1994018988A3 (en) Use of heparins for the treatment of inflammatory or immunological diseases
NO921086D0 (no) Fremgangsmaate for fremstilling og anvendelse av substituerte 2',3'-didesoksy-5-trifluormetyluridiner
NO905543L (no) Fremgangsmaate for fremstilling og anvendelse av aminopyridinylmetanoler og aminometylpyridinaminer.
NO981798D0 (no) FremgangsmÕte for fremstilling av faste legemiddelformer